Despite the widespread availability of analgesics, pain management remains one of the most significant and pervasive challenges in modern medicine, with more than 20% of the global population ...
Psoriasis is a chronic inflammatory skin disease affecting more than 60 million people worldwide, characterized by painful ...
Zoetis Inc. (NYSE: ZTS) today announced the commercial launch of Portela ® (relfovetmab) in Canada and the European Union (EU) member states. Portela is the first long-acting anti-nerve growth factor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results